635 related articles for article (PubMed ID: 32932156)
21. Next-generation cancer organoids.
LeSavage BL; Suhar RA; Broguiere N; Lutolf MP; Heilshorn SC
Nat Mater; 2022 Feb; 21(2):143-159. PubMed ID: 34385685
[TBL] [Abstract][Full Text] [Related]
22. Organoid technology in cancer precision medicine.
Xia X; Li F; He J; Aji R; Gao D
Cancer Lett; 2019 Aug; 457():20-27. PubMed ID: 31078736
[TBL] [Abstract][Full Text] [Related]
23. Patient-Derived Organoids for In Vivo Validation of In Vitro Data.
Kdimati S; Bürtin F; Linnebacher M; Mullins CS
Methods Mol Biol; 2023; 2589():111-126. PubMed ID: 36255621
[TBL] [Abstract][Full Text] [Related]
24. Use of Organoids to Characterize Signaling Pathways in Cancer Initiation.
Oatway C; Hirsch CL; Gregorieff A
Methods Mol Biol; 2018; 1765():315-331. PubMed ID: 29589318
[TBL] [Abstract][Full Text] [Related]
25. [Establishment and application of gastric and gastric cancer organoids].
Fan S; Yin J; Wang M; Guan W
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1315-1320. PubMed ID: 30506544
[TBL] [Abstract][Full Text] [Related]
26. Progress in the application of organoids to breast cancer research.
Yang L; Liu B; Chen H; Gao R; Huang K; Guo Q; Li F; Chen W; He J
J Cell Mol Med; 2020 May; 24(10):5420-5427. PubMed ID: 32283573
[TBL] [Abstract][Full Text] [Related]
27. Modeling neoplastic disease with spheroids and organoids.
Zanoni M; Cortesi M; Zamagni A; Arienti C; Pignatta S; Tesei A
J Hematol Oncol; 2020 Jul; 13(1):97. PubMed ID: 32677979
[TBL] [Abstract][Full Text] [Related]
28. High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids.
Choo N; Ramm S; Luu J; Winter JM; Selth LA; Dwyer AR; Frydenberg M; Grummet J; Sandhu S; Hickey TE; Tilley WD; Taylor RA; Risbridger GP; Lawrence MG; Simpson KJ
SLAS Discov; 2021 Oct; 26(9):1107-1124. PubMed ID: 34111999
[TBL] [Abstract][Full Text] [Related]
29. Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy.
Qu J; Kalyani FS; Liu L; Cheng T; Chen L
Cancer Commun (Lond); 2021 Dec; 41(12):1331-1353. PubMed ID: 34713636
[TBL] [Abstract][Full Text] [Related]
30. Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine.
Praharaj PP; Bhutia SK; Nagrath S; Bitting RL; Deep G
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):117-127. PubMed ID: 29360544
[TBL] [Abstract][Full Text] [Related]
31. Human neural organoids: Models for developmental neurobiology and disease.
Guy B; Zhang JS; Duncan LH; Johnston RJ
Dev Biol; 2021 Oct; 478():102-121. PubMed ID: 34181916
[TBL] [Abstract][Full Text] [Related]
32. Stem cell-derived organoids and their application for medical research and patient treatment.
Bartfeld S; Clevers H
J Mol Med (Berl); 2017 Jul; 95(7):729-738. PubMed ID: 28391362
[TBL] [Abstract][Full Text] [Related]
33. An Organoid-Based Preclinical Model of Human Gastric Cancer.
Steele NG; Chakrabarti J; Wang J; Biesiada J; Holokai L; Chang J; Nowacki LM; Hawkins J; Mahe M; Sundaram N; Shroyer N; Medvedovic M; Helmrath M; Ahmad S; Zavros Y
Cell Mol Gastroenterol Hepatol; 2019; 7(1):161-184. PubMed ID: 30522949
[TBL] [Abstract][Full Text] [Related]
34. Vascularized tissue on mesh-assisted platform (VT-MAP): a novel approach for diverse organoid size culture and tailored cancer drug response analysis.
Lee J; Jung S; Hong HK; Jo H; Rhee S; Jeong YL; Ko J; Cho YB; Jeon NL
Lab Chip; 2024 Apr; 24(8):2208-2223. PubMed ID: 38533822
[TBL] [Abstract][Full Text] [Related]
35. Cancer research using organoid technology.
Kretzschmar K
J Mol Med (Berl); 2021 Apr; 99(4):501-515. PubMed ID: 33057820
[TBL] [Abstract][Full Text] [Related]
36. Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening.
Boretto M; Maenhoudt N; Luo X; Hennes A; Boeckx B; Bui B; Heremans R; Perneel L; Kobayashi H; Van Zundert I; Brems H; Cox B; Ferrante M; Uji-I H; Koh KP; D'Hooghe T; Vanhie A; Vergote I; Meuleman C; Tomassetti C; Lambrechts D; Vriens J; Timmerman D; Vankelecom H
Nat Cell Biol; 2019 Aug; 21(8):1041-1051. PubMed ID: 31371824
[TBL] [Abstract][Full Text] [Related]
37. Glioblastoma Model Using Human Cerebral Organoids.
Ogawa J; Pao GM; Shokhirev MN; Verma IM
Cell Rep; 2018 Apr; 23(4):1220-1229. PubMed ID: 29694897
[TBL] [Abstract][Full Text] [Related]
38. Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity.
Tanaka N; Osman AA; Takahashi Y; Lindemann A; Patel AA; Zhao M; Takahashi H; Myers JN
Oral Oncol; 2018 Dec; 87():49-57. PubMed ID: 30527243
[TBL] [Abstract][Full Text] [Related]
39. The potential of organoids in urological cancer research.
Wang S; Gao D; Chen Y
Nat Rev Urol; 2017 Jul; 14(7):401-414. PubMed ID: 28534535
[TBL] [Abstract][Full Text] [Related]
40. Establishment of patient-derived three-dimensional organoid culture in renal cell carcinoma.
Na JC; Kim JH; Kim SY; Gu YR; Jun DY; Lee HH; Yoon YE; Choi KH; Hong SJ; Han WK
Investig Clin Urol; 2020 Mar; 61(2):216-223. PubMed ID: 32158973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
